Research.Patient.info
Retinopathy of Prematurity research hub
2 indexed studies · 1 currently recruiting
- recruiting
An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)
This study looks at how a medicine called aflibercept (Eylea) is used for premature babies in the UK who have an eye condition called Retinopathy of Prematurity (ROP). It's an information-gathering study to see how many babies are treated this way and to consider future research.
United Kingdom - ongoing, recruitingTherapeutic confirmatory (Phase III)
(20275) An extension study to evaluate the long-term outcomes of subjects who received treatment for retinopathy of prematurity in Study 20090
This study is looking at the long-term health of children, up to five years old, who received treatment for an eye condition called retinopathy of prematurity (ROP). Specifically, it will check their eyesight and overall development to see how well they are doing after treatment.
Sweden · Italy · Portugal